Medication info
Escarb Tablets 60/5 mg

Escarb Tablets 60/5 mg

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›7.48mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
Orange colored, rounded square film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300053 · Approved 2023.01.05 · Insurance code 657308800

Summary

Main use
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended to adjust the dose of fimasartan before administering this medicine; however, if blood pressure is not controlled as follows, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. No initial dosage adjustment is necessary in elderly patients 70 years of age or younger. No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. No dosage adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy in pediatric and adolescent patients 18 years of age or younger have not been established.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with fimasartan monotherapy

  • Essential Hypertension
View approved original text

This medicine can be an effective treatment option for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with pimodizide potassium. Essential hypertension can raise blood pressure, putting strain on the heart and blood vessels, making proper management crucial. This drug helps stabilize blood pressure more reliably, aiding in the prevention of complications. Therefore, it is used when additional control is needed alongside treatment using pimodizide potassium.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended to adjust the dose of fimasartan before administering this medicine; however, if blood pressure is not controlled as follows, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. No initial dosage adjustment is necessary in elderly patients 70 years of age or younger. No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. No dosage adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy in pediatric and adolescent patients 18 years of age or younger have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if used during pregnancy, especially in the 2nd and 3rd trimesters; therefore, it should be discontinued immediately once pregnancy is confirmed. Patients with allergies to the active ingredient or similar drugs, those who are pregnant or breastfeeding, individuals undergoing dialysis, patients with severe liver disease, those with bile duct obstruction, diabetic patients with certain kidney diseases, individuals with specific genetic lactose intolerance, patients with severe aortic stenosis, patients in shock, etc., should not take this medication. Patients with reduced blood volume or salt, impaired kidney function, renal vascular hypertension, aortic stenosis and mitral valve stenosis, primary aldosteronism, severe hypotension, elderly patients, and those allergic to certain colorants in the medication should use this medicine cautiously. While taking this drug, side effects such as dizziness, headache, facial swelling, urinary disorders, insomnia, flushing may occur, and serious kidney issues or blood pressure drops may also occur in rare cases; any abnormal symptoms should prompt immediate consultation with medical personnel. During use, there may be risks of too low blood pressure or electrolyte imbalances, especially when taken alongside diuretics or with dietary restrictions; hence caution is necessary, and appropriate measures should be taken if symptoms arise. This medication may interact with other antihypertensive agents, potassium-sparing diuretics, lithium, and non-steroidal anti-inflammatory drugs. If taking other medications, be sure to inform your doctor or pharmacist. It should be avoided during pregnancy due to serious risks to the fetus and should be discussed with a professional during breastfeeding since the drug may be passed through breast milk. Safety and efficacy for pediatric patients under 18 years have not been established, and elderly patients may be more sensitive to the medication and require caution during use. In cases of overdose, severe hypotension and heart problems may occur, so seek appropriate medical treatment immediately.

Side effects

  • Dizziness
  • postural dizziness
  • headache
  • facial swelling
  • peripheral edema
  • urination disorder
  • insomnia
  • flushing
  • syncope
  • sedation
Show 183 more
  • migraine
  • indigestion
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • itching
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • pulmonary fibrosis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • worsening low back pain
  • osteoarthritis
  • arthralgia
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • hypertension
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • chest pain
  • low back pain
  • edema
  • limb pain
  • fatigue
  • fever
  • neck/shoulder pain
  • fracture
  • myalgia
  • pharyngitis
  • upper respiratory infection
  • sputum
  • rhinitis
  • epistaxis
  • bronchitis
  • sensory abnormalities
  • numbness
  • tremor
  • hypertonia
  • insomnia
  • depression
  • anxiety
  • memory impairment
  • loss of appetite
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • constipation
  • functional bowel disorder
  • dysuria
  • hyperlipidemia
  • dyslipidemia
  • tinnitus
  • hearing impairment
  • hearing loss
  • pelvic inflammatory disease
  • vaginitis
  • benign prostatic hyperplasia
  • scrotal pain
  • blood pressure changes
  • fatty liver
  • localized inflammation
  • soft tissue infection
  • lymphadenopathy
  • postoperative pain
  • allergy
  • chills
  • nasal polyps
  • pneumonia
  • hemoptysis
  • asthma
  • pulmonary granuloma
  • abnormal chest X-ray
  • sputum
  • bronchitis
  • hypercholesterolemia
  • diabetes mellitus
  • hypertriglyceridemia
  • thirst
  • worsening diabetes mellitus
  • calcinosis
  • hyponatremia
  • gout
  • eye pain
  • retinal disease
  • glaucoma
  • cataracts
  • double vision
  • floaters
  • uveitis
  • worsening chronic renal failure
  • cystitis
  • urinary tract infection
  • increased BUN
  • pyelonephritis
  • frequent urination
  • abscess
  • bacterial infection
  • genital herpes
  • herpes labialis
  • shingles
  • thrombocythemia
  • panic response
  • Alzheimer’s disease
  • suicide attempt
  • restlessness
  • insomnia
  • depression
  • hyperthyroidism
  • hypothyroidism
  • increased TSH
  • atrial fibrillation
  • arrhythmia
  • tachycardia
  • myeloproliferative disorder
  • worsening anemia
  • iron deficiency anemia
  • tinnitus
  • hearing impairment
  • hearing loss
  • pelvic inflammatory disease
  • vaginitis
  • uterine prolapse
  • benign prostatic hyperplasia
  • scrotal pain
  • hypertension
  • purpura
  • fatty liver
  • pulmonary embolism
  • lymphadenopathy
  • postoperative pain
  • allergy
  • chills
  • nasal polyps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a container that protects from light. Additionally, it is best stored at room temperature between 1 to 30 degrees Celsius. This helps maintain the drug's effectiveness and safety.

Appearance and packaging

Appearance

Orange colored, rounded square film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.